Article
A eukaryotic molecular target candidate of roxithromycin: fungal differentiation as a sensitive drug target analysis system.
Bioscience, biotechnology, and biochemistry - 1 Jan 2013
Ishii Akira, Kumasaka Mayu, Nagashima Yuka, Nakajima Yuichi, Kuramochi Kouji, Sugawara Fumio, Narukawa Megumi, Kamakura Takashi
Abstract excerpt
Roxithromycin (RXM), active against prokaryotes, has beneficial side effects such as anti-cancer activities on mammalian cells, but the mechanisms underlying these effects remain unclear. We found that RXM inhibited the cellular differentiation of the rice blast fungus Magnaporthe oryzae. Hence,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
